loading

Halozyme Therapeutics Inc 주식(HALO)의 최신 뉴스

pulisher
09:40 AM

Here's Why Halozyme Therapeutics (HALO) is a Strong Value Stock - Yahoo Finance

09:40 AM
pulisher
06:54 AM

Aurora Investment Counsel Sells 12,753 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

06:54 AM
pulisher
05:10 AM

Segall Bryant & Hamill LLC Has $20.33 Million Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

05:10 AM
pulisher
Nov 20, 2024

Halozyme says €2 billion takeover of Evotech would create leader in drug discovery - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Breaking Down Halozyme Therapeutics: 10 Analysts Share Their Views - Benzinga

Nov 20, 2024
pulisher
Nov 20, 2024

Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Evotec jumps on report Halozyme expressed takeover interest - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO) - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec Deal - Seeking Alpha

Nov 19, 2024
pulisher
Nov 19, 2024

Halozyme Therapeutics (NASDAQ:HALO) Shares Gap UpHere's Why - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now? - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? - Yahoo Finance

Nov 19, 2024
pulisher
Nov 19, 2024

Evotec weakPossible defense battle dampens takeover fantasy - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Victory Capital Management Inc. Has $23.29 Million Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Halozyme CEO: Evotec Is Poised for Growth - Marketscreener.com

Nov 18, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 18, 2024

Halozyme Bids €2B for Evotec, Eyes $2B Revenue by 2025 in Pharma Services Push | EVO Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 18, 2024

Royce & Associates LP Decreases Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Halozyme (HALO) Eyes $21 Billion Cash Acquisition of Evotec (EVO) - GuruFocus.com

Nov 18, 2024
pulisher
Nov 17, 2024

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - Yahoo Finance

Nov 17, 2024
pulisher
Nov 17, 2024

The week in pharma: action, reaction and insight – week to November 15 - The Pharma Letter

Nov 17, 2024
pulisher
Nov 17, 2024

Cornercap Investment Counsel Inc. Sells 20,204 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

South Street Advisors LLC Purchases New Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Mizuho Markets Americas LLC Trims Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 16, 2024
pulisher
Nov 16, 2024

Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer - MSN

Nov 16, 2024
pulisher
Nov 15, 2024

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion - AOL

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme Makes Unsolicited €2B Takeover Bid for Drug R&D Services Firm Evotec - MedCity News

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme Therapeutics (NASDAQ:HALO) Shares Gap DownHere's What Happened - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme Bid For Evotec Does Not Look High Enough - Citeline News & Insights

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme keeps Neutral rating, price target set on acquisition interest By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme offers €11 per share to acquire Evotec for €2bn - World Pharmaceutical Frontiers

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme sets out offer to acquire Evotec - The Pharma Letter

Nov 15, 2024
pulisher
Nov 15, 2024

Evotec spikes on buyout proposal from Halozyme - FirstWord Pharma

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme offers $2B for Evotec to expand beyond tech used by J&J - Fierce Biotech

Nov 15, 2024
pulisher
Nov 15, 2024

US competitor Halozyme offers two billion euros for Evotec - Marketscreener.com

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme bids for Evotec; BeiGene gets a new name - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Evotec surges on Halozyme takeover interest - ShareCast

Nov 15, 2024
pulisher
Nov 15, 2024

Market news - Research the market

Nov 15, 2024
pulisher
Nov 15, 2024

Germany’s Evotec Gets Takeover Interest From Halozyme - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme (HALO) Aims for Global Innovation through Evotec Purchase - Value the Markets

Nov 15, 2024
pulisher
Nov 15, 2024

HALOZYME THERAPEUTICS INC : JP Morgan gives a Neutral rating - Marketscreener.com

Nov 15, 2024
pulisher
Nov 14, 2024

Halozyme proposes $2 billion acquisition of Evotec - Investing.com India

Nov 14, 2024
pulisher
Nov 14, 2024

Halozyme Therapeutics Bids to Acquire German Competitor Evotec - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

Halozyme weighing buyout of drugmaker Evotec, Bloomberg News reports - MSN

Nov 14, 2024
pulisher
Nov 14, 2024

Halozyme makes 2 billion euro buyout offer for drug developer Evotec - Reuters.com

Nov 14, 2024
pulisher
Nov 14, 2024

Halozyme Bids €2B to Acquire Evotec, Offers 109% Premium in Major Biotech Deal | HALO Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Evotec jumps as Halozyme confirms takeover interest (updated) - Seeking Alpha

Nov 14, 2024
pulisher
Nov 14, 2024

Halozyme interested in acquiring Evotec for $2.1B, Bloomberg says - TipRanks

Nov 14, 2024
pulisher
Nov 13, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Sold by Future Fund LLC - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Principal Financial Group Inc. Trims Stock Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Acquired by Janney Montgomery Scott LLC - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

Artisan Partners Limited Partnership Adjusts Stake in Halozyme T - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

How the (HALO) price action is used to our Advantage - Stock Traders Daily

Nov 12, 2024
pulisher
Nov 12, 2024

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stake Lessened by WCM Investment Management LLC - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Assetmark Inc. Has $5.33 Million Position in Halozyme Therapeutics, Inc. (NASDAQ:HALO) - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

Needle Free Injectors Market Is Expected To Reach a Revenue Of USD 2,980.9 Million By 2033, At 8.1% CAGR: Dimension Market Research - GlobeNewswire Inc.

Nov 11, 2024
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):